P

Inventor

FALB DEAN

US23 patents
⚠️ This page may combine multiple inventors who share the name “FALB DEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SYNLOGIC OPERATING CO INC

19 patents
US11471494B2Oct 18, 2022

Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells

SYNLOGIC OPERATING CO INC7 citations84
US11291693B2Apr 5, 2022

Bacteria engineered to treat metabolic diseases

SYNLOGIC OPERATING CO INC9 citations84
US11060073B2Jul 13, 2021

Bacteria engineered to treat diseases associated with hyperammonemia

SYNLOGIC OPERATING CO INC5 citations83
US10933102B2Mar 2, 2021

Bacteria engineered to treat a disease or disorder

SYNLOGIC OPERATING CO INC7 citations83
US10610546B2Apr 7, 2020

Bacteria engineered to reduce hyperphenylalaninemia

SYNLOGIC OPERATING CO INC7 citations83
US10273489B2Apr 30, 2019

Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier

SYNLOGIC OPERATING CO INC12 citations83
US10195234B2Feb 5, 2019

Bacteria engineered to reduce hyperphenylalaninemia

SYNLOGIC OPERATING CO INC6 citations83
US11723932B2Aug 15, 2023

Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells

SYNLOGIC OPERATING CO INC5 citations74
US11618894B2Apr 4, 2023

Bacteria engineered to reduce hyperphenylalaninemia

SYNLOGIC OPERATING CO INC5 citations74
US11879123B2Jan 23, 2024

Bacteria for the treatment of disorders

SYNLOGIC OPERATING CO INC4 citations71
US12409195B2Sep 9, 2025

Bacteria engineered to reduce hyperphenylalaninemia

SYNLOGIC OPERATING CO INC0 citations62
US11845964B2Dec 19, 2023

Bacteria engineered to treat diseases associated with hyperammonemia

SYNLOGIC OPERATING CO INC0 citations62
US11685925B2Jun 27, 2023

Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier

SYNLOGIC OPERATING CO INC0 citations62
US11384359B2Jul 12, 2022

Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier

SYNLOGIC OPERATING CO INC0 citations62
US11896627B2Feb 13, 2024

Bacteria engineered to treat metabolic diseases

SYNLOGIC OPERATING CO INC0 citations60
US12545886B2Feb 10, 2026

Bacteria for the treatment of disorders

SYNLOGIC OPERATING CO INC0 citations59
US11273184B2Mar 15, 2022

Bacteria engineered to treat disorders in which oxalate is detrimental

SYNLOGIC OPERATING CO INC0 citations54
US11883439B2Jan 30, 2024

Bacteria engineered to treat a disease or disorder

SYNLOGIC OPERATING CO INC0 citations51
US11439673B2Sep 13, 2022

Bacteria engineered to treat liver disease

SYNLOGIC OPERATING CO INC0 citations51

SYNLOGIC INC

4 patents